4 assets in Hormone-Resistant Breast Carcinoma

Therapeutic assets addressing Hormone-Resistant Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
ag-01 compound Hormone-Resistant Breast Carcinoma	A&G Pharmaceutical Inc.	P1	CC (43)
Fulvestrant Hormone-Resistant Breast Carcinoma	Fudan University	N/A	D (30)
Palbociclib Hormone-Resistant Breast Carcinoma	Fudan University	N/A	D (30)
Sirolimus Hormone-Resistant Breast Carcinoma	Fudan University	N/A	D (30)